文献速递儿童感染新生儿

孕妇与新生儿人乳头瘤病毒的传播与持续存在

Human Papillomavirus Transmission and Persistence in Pregnant Women and Neonates.
PubMed 文献 · JAMA Pediatr · 2023-01-01

该前瞻性队列研究纳入1050名孕早期孕妇,孕妇HPV感染率为40.3%,胎盘HPV检出率为10.7%,新生儿HPV检出率为7.2%,但出生时检出的HPV均在6月龄前清除。围产期传播不常见,且未观察到新生儿期感染持续至6个月。

要点

  • 孕妇HPV感染率较高(40.3%),其中66.4%携带至少一种高危型别。
  • 新生儿HPV检出率为7.2%,最常见部位为结膜(3.2%)。
  • 出生时检出的HPV均在6月龄前清除,未见持续感染。

核心结论

  • 孕妇阴道HPV检出常见,但围产期传播不频繁,且出生时检出的HPV无持续至6个月者。

主要发现

  • 孕妇招募时HPV感染率为40.3%(95%CI 37.3%-43.3%)。
  • 422名HPV阳性孕妇中,280名(66.4%)携带至少1种高危型别,190名(45.0%)合并多种基因型感染。
  • 胎盘HPV检出率为10.7%(92/860;95%CI 8.8%-12.9%),羊膜下胎儿侧活检阳性率仅3.9%(14/361)。
  • 新生儿HPV检出率(出生时和/或3月龄)为7.2%(95%CI 5.0%-10.3%),最常见部位为结膜(3.2%;95%CI 1.8%-5.6%),其次为口腔(2.9%;95%CI 1.6%-5.2%)、生殖器部位(2.7%;95%CI 1.4%-4.9%)和咽部(0.8%;95%CI 0.2%-2.5%)。
  • 所有出生时检出的儿童HPV均在6月龄前清除。

临床怎么用

  • 孕妇HPV感染常见,但围产期传播风险较低,出生时检出的HPV多为一过性,无需过度干预。

局限性

  • 胎盘HPV检测难以区分污染与真性感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The prevalence of human papillomavirus (HPV) infection during pregnancy and its risk of transmission to newborns are not well documented. OBJECTIVE: To ascertain the prevalence of HPV in pregnant women, the risk of HPV detection in the placenta and in children at birth, and the probability that HPV detected at birth may persist in newborns. DESIGN, SETTING, AND PARTICIPANTS: The Human Papillomavirus Perinatal Transmission and Risk of HPV Persistence Among Children (HERITAGE) study was a prospective cohort study that recruited participants between November 8, 2010, and October 16, 2016. Participant follow-up visits were completed on June 15, 2017. Participants, which included pregnant women of at least 18 years of age and at 14 weeks or earlier of gestation, were recruited from 3 academic hospitals in Montreal, Québec, Canada. Laboratory and statistical analysis were completed on November 15, 2022. EXPOSURES: HPV DNA testing on self-collected vaginal and placental samples. Among children of mothers positive for HPV, conjunctival, oral, pharyngeal, and genital samples were collected for HPV DNA testing. MAIN OUTCOMES AND MEASURES: Vaginal HPV DNA testing was done on self-collected vaginal samples obtained among pregnant women recruited during their first trimester of pregnancy and in the third trimester for those who had HPV-positive samples in the first trimester. HPV DNA testing was also done on placental samples (swabs and biopsies) collected after birth in all participants. HPV DNA testing among children included conjunctival, oral, pharyngeal, and genital samples collected in children of HPV-positive mothers at birth, 3 months, and 6 months of age. RESULTS: A total of 1050 pregnant women (mean [SD] age, 31.3 [4.7] years) were included in this study. Prevalence of HPV in pregnant women at recruitment was 40.3% (95% CI, 37.3%-43.3%). Among the 422 HPV-positive women, 280 (66.4%) harbored at least 1 high-risk genotype, and 190 (45.0%) were coinfected with multiple genotypes. HPV was detected in 10.7% of placentas (92 of 860; 95% CI, 8.8%-12.9%) overall, but only 3.9% of biopsies (14 of 361) on the fetal side under the amniotic membrane were positive. Neonatal HPV detection (at birth and/or at 3 months) was 7.2% (95% CI, 5.0%-10.3%) overall, with the most frequent site of infection being the conjunctiva (3.2%; 95% CI, 1.8%-5.6%), followed by the mouth (2.9%; 95% CI, 1.6%-5.2%), the genital area (2.7%; 95% CI, 1.4%-4.9%), and the pharynx (0.8%; 95% CI, 0.2%-2.5%). Importantly, all HPV detected in children at birth cleared before the age of 6 months. CONCLUSIONS AND RELEVANCE: In this cohort study, vaginal HPV was frequently detected in pregnant women. Perinatal transmission was infrequent, and in this cohort, no infection detected at birth persisted at 6 months. Although HPV was detected in placentas, it remains difficult to differentiate contamination vs true infection.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Khayargoli P, Niyibizi J, Mayrand MH, et al. Human Papillomavirus Transmission and Persistence in Pregnant Women and Neonates. JAMA Pediatr. 2023. PMID: 37213128. doi:10.1001/jamapediatrics.2023.1283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。